Skip to main content

Closed

CLNN: Clene Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-41.5% / yr

Operating margin-15535.1%

ROIC-118.1%

Financially safe

Stretched

Debt / equity-1.17×

Interest coverage-7.3×

Current ratio1.94×

Clene Inc.

CLNNNASDAQ Capital Market·USD·Closed

Clene Inc.

CLNNNASDAQ·USD·Closed

$5.01

−0.50%

$5.01

−$0.03 (0.50%)

52W Range

17thpctl

Volume

0.07×avg

Mkt Cap

51.69MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.07×avg

Market Cap

51.69MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings